ArticleCancer discovery2024

Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors.

Eric Y Stutheit-Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.